We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$43.8B
AUM Growth
+$1B
Cap. Flow
-$59.5M
Cap. Flow %
-0.14%
Top 10 Hldgs %
14.97%
Holding
3,057
New
207
Increased
1,365
Reduced
1,344
Closed
128

Sector Composition

Rank Sector Weight
1 Financials 16.4%
2 Technology 15.29%
3 Healthcare 13.69%
4 Industrials 10.84%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDTX
2926
DELISTED
Cidara Therapeutics
CDTX
-695
Closed -$108K
CRDF icon
2927
Cardiff Oncology
CRDF
$63M
-516
Closed -$43K
DWSN icon
2928
Dawson Geophysical
DWSN
$130M
-26,780
Closed -$142K
DXLG icon
2929
Destination XL Group
DXLG
$32.9M
-38,928
Closed -$111K
ELDN icon
2930
Eledon Pharmaceuticals
ELDN
$255M
-197
Closed -$27K
FCEL icon
2931
FuelCell Energy
FCEL
$1.45B
-74
Closed -$37K
GLOB icon
2932
Globant
GLOB
$1.65B
-27,654
Closed -$1.01M
GSM icon
2933
FerroAtlántica
GSM
$590M
-81,001
Closed -$837K
IMUX icon
2934
Immunic
IMUX
$178M
-64
Closed -$103K
IWO icon
2935
iShares Russell 2000 Growth ETF
IWO
$14.1B
-11,775
Closed -$1.9M
IWP icon
2936
iShares Russell Mid-Cap Growth ETF
IWP
$19.4B
-70,240
Closed -$3.64M
JAKK icon
2937
Jakks Pacific
JAKK
$303M
-2,289
Closed -$126K
LFVN icon
2938
LifeVantage
LFVN
$80.1M
-11,551
Closed -$62K
LPCN icon
2939
Lipocine
LPCN
$17.1M
-773
Closed -$51K
LRMR icon
2940
Larimar Therapeutics
LRMR
$377M
-2,325
Closed -$130K
LWAY icon
2941
Lifeway Foods
LWAY
$480M
-10,589
Closed -$114K
MCHX icon
2942
Marchex
MCHX
$77.8M
-43,016
Closed -$117K
MNKD icon
2943
MannKind Corp
MNKD
$1.19B
-72,108
Closed -$107K
NDLS icon
2944
Noodles & Co
NDLS
$95.1M
-1,273
Closed -$59K
NGVC icon
2945
Vitamin Cottage Natural Grocers
NGVC
$760M
-10,518
Closed -$109K
RCKT icon
2946
Rocket Pharmaceuticals
RCKT
$343M
-7,456
Closed -$60K
RGLS
2947
DELISTED
Regulus Therapeutics
RGLS
-463
Closed -$92K
SENS icon
2948
Senseonics Holdings Inc
SENS
$254M
-1,147
Closed -$41K
SILC icon
2949
Silicom
SILC
$201M
-5,749
Closed -$286K
DCOY
2950
Decoy Therapeutics
DCOY
$2.14M
0
-$62K

Similar funds

RhumbLine Advisers's Q2 2017 Portfolio in Review

As of Q2 2017, RhumbLine Advisers held 3,057 positions worth $43.8B, up 2.3% from $42.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q2 2017 filing shows 207 new, 1,365 increased, 1,344 reduced and 128 closed positions. Its largest new stake was DXC Technology: 615,360 shares worth $40.8M. The largest sale was Yahoo Inc, an estimated $68.4M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q2 2017 buy was DXC Technology: 615,360 shares worth $40.8M.
  • RhumbLine Advisers added most to IHS Markit Ltd. Common Shares in Q2 2017, an estimated $26.7M increase.
  • RhumbLine Advisers's biggest Q2 2017 reduction was Apple, cutting an estimated $23.6M.
  • RhumbLine Advisers fully exited Yahoo Inc in Q2 2017, selling an estimated $68.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $43.8B portfolio in Q2 2017.
  • RhumbLine Advisers opened 207 new positions and closed 128 in Q2 2017.
  • RhumbLine Advisers's portfolio value rose 2.3% quarter-over-quarter to $43.8B.

Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.